Cardinal Point Capital Management’s Edwards Lifesciences EW Stock Holding History

Cardinal Point Capital Management’s Portfolio EW Stock Details EW Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$216K	Buy	+2,392	New	+$200K	0.01%	281

Other funds holding EW

Ninety One (UK) London, United Kingdom $44.7B AUM 17.24% 1-Year Est. Return

Wellcome Trust London, United Kingdom $9.01B AUM 12.05% 1-Year Est. Return

Assenagon Asset Management Senningerberg, Luxembourg $80.2B AUM 50.57% 1-Year Est. Return

Handelsbanken Fonder Stockholm, Sweden $35.1B AUM 47.76% 1-Year Est. Return

BHIA

Birch Hill Investment Advisors Boston, Massachusetts $2.47B AUM 20.95% 1-Year Est. Return

NONA

Ninety One North America New York $2.13B AUM 9.16% 1-Year Est. Return

Robeco Institutional Asset Management Rotterdam, Netherlands $81.4B AUM 40.71% 1-Year Est. Return

SIM

Seilern Investment Management London, United Kingdom $794M AUM 6.63% 1-Year Est. Return

OIAM

OFI Invest Asset Management Paris, France $10B AUM 48.47% 1-Year Est. Return

FFM

Fisher Funds Management Auckland, New Zealand $3.52B AUM 17.59% 1-Year Est. Return

Cardinal Point Capital Management's EW Position: Q2 2026 in Review

Cardinal Point Capital Management opened a new position in Edwards Lifesciences (EW) in Q2 2026: 2,392 shares worth $216K. The stake represents 0.01% of the portfolio and ranks #281 among its holdings.

276 funds tracked by Wall St. Rank hold EW as of Q2 2026.

Cardinal Point Capital Management held 2,392 shares of Edwards Lifesciences worth $216K as of Q2 2026.
Edwards Lifesciences was a new Cardinal Point Capital Management position in Q2 2026.
Edwards Lifesciences made up 0.01% of Cardinal Point Capital Management's portfolio in Q2 2026, its #281 holding.
276 funds tracked by Wall St. Rank held Edwards Lifesciences as of Q2 2026.

Based on Cardinal Point Capital Management's 13F filing for Q2 2026, filed 14 Jul 2026.